Home/Filings/4/0001104659-25-006841
4//SEC Filing

Harris Matthew Scott 4

Accession 0001104659-25-006841

CIK 0001326190other

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 9:05 PM ET

Size

22.6 KB

Accession

0001104659-25-006841

Insider Transaction Report

Form 4
Period: 2025-01-25
Harris Matthew Scott
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2025-01-25+14,60043,800 total
    Common Stock, par value $0.0001 (14,600 underlying)
  • Award

    Stock Options (option to buy)

    2025-01-27+183,600183,600 total
    Exercise: $7.00Exp: 2035-01-27Common Stock, par value $0.0001 (183,600 underlying)
  • Exercise/Conversion

    Common Stock, par value $0.0001

    2025-01-25+14,60069,719 total
  • Tax Payment

    Common Stock, par value $0.0001

    2025-01-25$6.98/sh4,994$34,85864,725 total
  • Award

    Restricted Stock Units

    2025-01-27+63,40063,400 total
    Common Stock, par value $0.0001 (63,400 underlying)
Footnotes (5)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
  • [F2]Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
  • [F3]The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
  • [F4]Twenty-five percent of the shares underlying the option become vested and released on January 27, 2026 and the remaining 75% of the shares underlying the option become vested and released in substantially equal monthly installments over the 36 months following January 27, 2026, subject to the reporting person's continued service through the applicable vesting date.
  • [F5]The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.

Issuer

Altimmune, Inc.

CIK 0001326190

Entity typeother

Related Parties

1
  • filerCIK 0001787762

Filing Metadata

Form type
4
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 9:05 PM ET
Size
22.6 KB